Last reviewed · How we verify
HAL-MPE1
At a glance
| Generic name | HAL-MPE1 |
|---|---|
| Also known as | Modified peanut extract, Placebo for modified peanut extract, HAL-MPE1: modified peanut extract |
| Sponsor | HAL Allergy |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- HAL-MPE1 Safety and Tolerability Study (PHASE1)
- HAL-MPE1 First-in-human (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HAL-MPE1 CI brief — competitive landscape report
- HAL-MPE1 updates RSS · CI watch RSS
- HAL Allergy portfolio CI